Alex Kotzer
No más puestos en curso
Historial de carrera de Alex Kotzer
Antiguos cargos conocidos de Alex Kotzer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Director Ejecutivo | 25/03/2010 | - |
| Presidente | 25/03/2010 | - | |
| COMPUGEN LTD. | Director/Miembro de la Junta | 03/06/2009 | - |
| Presidente | 01/09/2005 | 03/06/2009 |
Formación de Alex Kotzer.
| Technion-Israel Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Israel | 4 |
Operativa
| Director/Board Member | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Alex Kotzer
- Experiencia
